| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615156 | Clinical Lymphoma Myeloma and Leukemia | 2018 | 34 Pages |
Abstract
Although the overall risk of SCs in patients with HL declined after modifications in HL treatment, the risk did not change significantly at most individual sites. Thus, close follow-up with active surveillance for SCs is crucial for long-term survivors of HL.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Vivek Kumar, Mohit Garg, Abhinav B. Chandra, Valerie S. Mayorga, Salman Ahmed, Sikander Ailawadhi,